Evidence map›Paper›PMID 40283623›Full record

ArticleJournal of clinical medicine2025

Cardiotoxicity Associated with Venlafaxine-Defining Features in a Series of Five Cases and a Call for Proactive Monitoring.

Bujana Batusha Sopi, Keiko Yonekawa, Stefan Russmann, Jasminka Bernheim, Stefano Caselli, Christian Schmied, Helene Hammer, Anna Lam, Christine Attenhofer Jost

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bujana Batusha SopiHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.ORCID 0009-0005-1812-6466
Keiko YonekawaHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.
Stefan RussmannDrugsafety.ch, 8703 Küsnacht, Switzerland.
Jasminka BernheimHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.
Stefano CaselliHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.
Christian SchmiedHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.
Helene HammerHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.
Anna LamHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.ORCID 0000-0001-9827-9465
Christine Attenhofer JostHerzGefässZentrum Im Park, Hirslanden Klinik Im Park, 8038 Zürich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arrhythmiascardiomyopathycardiotoxicityheart failurevenlafaxine

Identifiers

PMID40283623
PMCPMC12028038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.